Venus Concept Stock Forecast, Price & News

-0.06 (-3.31 %)
(As of 05/6/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume272,654 shs
Average Volume788,975 shs
Market Capitalization$94.62 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VERO News and Ratings via Email

Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:VERO
Year FoundedN/A

Sales & Book Value

Annual Sales$110.41 million
Book Value$2.57 per share


Net Income$-40,620,000.00
Net Margins-104.71%




Market Cap$94.62 million
Next Earnings Date5/17/2021 (Confirmed)
OptionableNot Optionable


See More Headlines
Venus Concept logo

About Venus Concept

Venus Concept Inc. operates as a medical aesthetic technology company worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-treatment platform to address the aesthetic procedures without surgery or downtime; Venus Legacy, an advanced device that resolves challenging face and body aesthetic needs; Venus Velocity, a diode laser for hair removal; Venus Fiore, which addresses internal vaginal health restoration, labia skin tightening, and mons pubis reduction; Venus Viva, a customizable skin resurfacing device that allows operator control of ablation and coagulation for resolving the appearance of mild to severe skin damage for various skin types; Venus Freeze Plus, an anti-aging system for non-invasive skin tightening; and Venus Bliss, a solution for the fat reduction category. The company also offers NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process; and ARTAS and ARTAS iX robotic hair restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept Inc. is headquartered in Toronto, Canada.


Overall MarketRank

1.94 out of 5 stars

Medical Sector

79th out of 2,041 stocks

Surgical & Medical Instruments Industry

13th out of 169 stocks

Analyst Opinion: 3.4Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Venus Concept (NASDAQ:VERO) Frequently Asked Questions

Is Venus Concept a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Venus Concept stock.
View analyst ratings for Venus Concept
or view top-rated stocks.

What stocks does MarketBeat like better than Venus Concept?

Wall Street analysts have given Venus Concept a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Venus Concept wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Venus Concept's next earnings date?

Venus Concept is scheduled to release its next quarterly earnings announcement on Monday, May 17th 2021.
View our earnings forecast for Venus Concept

How can I listen to Venus Concept's earnings call?

Venus Concept will be holding an earnings conference call on Monday, May 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) released its quarterly earnings results on Monday, March, 29th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.06. The business earned $25.83 million during the quarter, compared to analysts' expectations of $25.70 million. Venus Concept had a negative net margin of 104.71% and a negative trailing twelve-month return on equity of 132.46%.
View Venus Concept's earnings history

How has Venus Concept's stock been impacted by COVID-19?

Venus Concept's stock was trading at $5.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VERO stock has decreased by 67.0% and is now trading at $1.75.
View which stocks have been most impacted by COVID-19

What guidance has Venus Concept issued on next quarter's earnings?

Venus Concept issued an update on its FY 2021 earnings guidance on Tuesday, April, 27th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $98 million-$103 million, compared to the consensus revenue estimate of $101.50 million.

What price target have analysts set for VERO?

5 analysts have issued twelve-month price objectives for Venus Concept's stock. Their forecasts range from $2.50 to $7.00. On average, they anticipate Venus Concept's share price to reach $5.10 in the next twelve months. This suggests a possible upside of 191.4% from the stock's current price.
View analysts' price targets for Venus Concept
or view top-rated stocks among Wall Street analysts.

Who are Venus Concept's key executives?

Venus Concept's management team includes the following people:
  • Mr. Domenic Serafino, CEO & Director (Age 60, Pay $551.82k)
  • Mr. Domenic Della Penna, Chief Financial Officer (Age 60, Pay $352.89k)
  • Mr. Soeren Maor Sinay, Chief Operating Officer (Age 50)
  • Ms. Melissa Kang, VP of Global Marketing (Age 54)
  • Ms. Anna Georgiadis, VP of Global HR (Age 50)
  • Mr. Chad A. Zaring, Chief Commercial Officer (Age 46)

Who are some of Venus Concept's key competitors?

What other stocks do shareholders of Venus Concept own?

What is Venus Concept's stock symbol?

Venus Concept trades on the NASDAQ under the ticker symbol "VERO."

Who are Venus Concept's major shareholders?

Venus Concept's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pacifica Partners Inc. (0.03%).
View institutional ownership trends for Venus Concept

Which institutional investors are buying Venus Concept stock?

VERO stock was purchased by a variety of institutional investors in the last quarter, including Pacifica Partners Inc..
View insider buying and selling activity for Venus Concept
or or view top insider-buying stocks.

How do I buy shares of Venus Concept?

Shares of VERO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Venus Concept's stock price today?

One share of VERO stock can currently be purchased for approximately $1.75.

How much money does Venus Concept make?

Venus Concept has a market capitalization of $94.62 million and generates $110.41 million in revenue each year. The company earns $-40,620,000.00 in net income (profit) each year or ($4.77) on an earnings per share basis.

How many employees does Venus Concept have?

Venus Concept employs 384 workers across the globe.

What is Venus Concept's official website?

The official website for Venus Concept is

Where are Venus Concept's headquarters?

Venus Concept is headquartered at 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8.

How can I contact Venus Concept?

Venus Concept's mailing address is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. The company can be reached via phone at 877-848-8430 or via email at [email protected]

This page was last updated on 5/7/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.